<?xml version="1.0" encoding="UTF-8"?>
<abstract id="16195287">
  <title>
    <s id="0" section="title">
      Effect of
      <group id="0">sublingual  misoprostol</group>
      on
      <outcome id="0">
        severe
        <short>postpartum  haemorrhage</short>
      </outcome>
      in a primary health centre in Guinea-Bissau : randomised double blind clinical trial .
    </s>
  </title>
  <annotated>
    <s id="1" section="objective">
      To evaluate whether
      <group id="0">
        routine  administration  of  sublingual
        <short>misoprostol</short>
        600  microg  after  delivery
      </group>
      reduces
      <outcome id="0">postpartum  haemorrhage</outcome>
      .
    </s>
    <s id="4" section="participants">
      <ps>661</ps>
      women undergoing vaginal delivery .
    </s>
    <s id="5" section="intervention">
      <group id="0">
        <short>Misoprostol</short>
        600  mug
      </group>
      or
      <group id="1">placebo</group>
      administered sublingually immediately after delivery .
    </s>
    <s id="6" section="main_outcome_measures">
      <outcome id="0">
        <short>Postpartum  haemorrhage</short>
        ,  defined  as  a  loss  of  &gt;  or  =  500  ml
      </outcome>
      and decrease in
      <outcome id="1">
        <short>haemoglobin  concentration</short>
        <time id="0">after  delivery</time>
      </outcome>
      .
    </s>
    <s id="7" section="results">
      The
      <outcome id="0">
        incidence  of
        <short>postpartum  haemorrhage</short>
      </outcome>
      was not significantly different between the 2 groups , the relative risk being 0.89 ( 95 % confidence interval 0.76 to 1.04 ) in the
      <group id="0">misoprostol  group</group>
      compared with the
      <group id="1">placebo  group</group>
      .
    </s>
    <s id="9" section="results">
      <outcome id="0">
        Severe
        <short>postpartum  haemorrhage</short>
        of  &gt;  or  =  1000  ml  or  &gt;  or  =  1500  ml
      </outcome>
      occurred in 17 % ( 56 ) and 8 % ( 25 ) in the
      <group id="1">placebo  group</group>
      and 11 % ( 37 ) and 2 % ( 7 ) in the
      <group id="0">misoprostol  group</group>
      .
    </s>
    <s id="10" section="results">
      Significantly fewer women in the
      <group id="0">misoprostol  group</group>
      experienced a
      <outcome id="0">
        <short>loss</short>
        of  &gt;  or  =  1000  ml  (  0.66  ,  0.45  to  0.98  )  or  &gt;  or  =  1500  ml  (  0.28  ,  0.12  to  0.64  )
      </outcome>
      .
    </s>
    <s id="11" section="results">
      The decrease in
      <outcome id="1">haemoglobin  concentration</outcome>
      tended to be less in the
      <group id="0">misoprostol  group</group>
      , the mean difference between the 2 groups being 0.16 mmol / l ( - 0.01 mmol / l to 0.32 mmol / l ) .
    </s>
  </annotated>
  <fulltext>Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau : randomised double blind clinical trial . To evaluate whether routine administration of sublingual misoprostol 600 microg after delivery reduces postpartum haemorrhage . Randomised double blind placebo controlled trial . Primary health centre in Bissau , Guinea-Bissau , West Africa . 661 women undergoing vaginal delivery . Misoprostol 600 mug or placebo administered sublingually immediately after delivery . Postpartum haemorrhage , defined as a loss of &gt; or = 500 ml and decrease in haemoglobin concentration after delivery . The incidence of postpartum haemorrhage was not significantly different between the 2 groups , the relative risk being 0.89 ( 95 % confidence interval 0.76 to 1.04 ) in the misoprostol group compared with the placebo group . Mean blood loss was 10.5 % ( - 0.5 % to 20.4 % ) lower in the misoprostol group than in the control group . Severe postpartum haemorrhage of &gt; or = 1000 ml or &gt; or = 1500 ml occurred in 17 % ( 56 ) and 8 % ( 25 ) in the placebo group and 11 % ( 37 ) and 2 % ( 7 ) in the misoprostol group . Significantly fewer women in the misoprostol group experienced a loss of &gt; or = 1000 ml ( 0.66 , 0.45 to 0.98 ) or &gt; or = 1500 ml ( 0.28 , 0.12 to 0.64 ) . The decrease in haemoglobin concentration tended to be less in the misoprostol group , the mean difference between the 2 groups being 0.16 mmol / l ( - 0.01 mmol / l to 0.32 mmol / l ) . Sublingual misoprostol reduces the frequency of severe postpartum haemorrhage .</fulltext>
  <ignored>
    <s id="2" section="design">Randomised double blind placebo controlled trial .</s>
    <s id="3" section="setting">Primary health centre in Bissau , Guinea-Bissau , West Africa .</s>
    <s id="8" section="results">
      <outcome id="2">Mean  blood  loss</outcome>
      was 10.5 % ( - 0.5 % to 20.4 % ) lower in the
      <group id="0">misoprostol  group</group>
      than in the
      <group id="1">control  group</group>
      .
    </s>
    <s id="12" section="conclusion">
      <group id="0">Sublingual  misoprostol</group>
      reduces the frequency of
      <outcome id="0">
        severe
        <short>postpartum  haemorrhage</short>
      </outcome>
      .
    </s>
  </ignored>
</abstract>

